Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $7.00 price target on shares of Aethlon Medical in a report on Friday, November 15th.

Aethlon Medical Stock Performance

Shares of AEMD opened at $0.66 on Friday. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $2.10. The firm has a market cap of $9.27 million, a price-to-earnings ratio of -0.24 and a beta of 1.61. The business’s fifty day moving average is $0.52 and its 200-day moving average is $0.44.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.